Ten years of Genome Medicine
-
Citation: Genome Medicine 2019 11:13
-
BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma
Malignant peritoneal mesothelioma (PeM) is a rare and fatal cancer that originates from the peritoneal lining of the abdomen. Standard treatment of PeM is limited to cytoreductive surgery and/or chemotherapy, ...
Citation: Genome Medicine 2019 11:8 -
Ten years of Genome Medicine
Citation: Genome Medicine 2019 11:7 -
Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations
While tumor genome sequencing has become widely available in clinical and research settings, the interpretation of tumor somatic variants remains an important bottleneck. Here we present the Cancer Genome Inte...
Citation: Genome Medicine 2018 10:25 -
Integrated Bayesian analysis of rare exonic variants to identify risk genes for schizophrenia and neurodevelopmental disorders
Integrating rare variation from trio family and case–control studies has successfully implicated specific genes contributing to risk of neurodevelopmental disorders (NDDs) including autism spectrum disorders (...
Citation: Genome Medicine 2017 9:114 -
Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer’s disease resilience
While age and the APOE ε4 allele are major risk factors for Alzheimer’s disease (AD), a small percentage of individuals with these risk factors exhibit AD resilience by living well beyond 75 years of age without ...
Citation: Genome Medicine 2017 9:100 -
Advances in the delivery of RNA therapeutics: from concept to clinical reality
The rapid expansion of the available genomic data continues to greatly impact biomedical science and medicine. Fulfilling the clinical potential of genetic discoveries requires the development of therapeutics ...
Citation: Genome Medicine 2017 9:60 -
Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial
The clinical utility of molecular profiling of tumor tissue to guide treatment of patients with advanced solid tumors is unknown. Our objectives were to evaluate the frequency of genomic alterations, clinical ...
Citation: Genome Medicine 2016 8:109 -
The early infant gut microbiome varies in association with a maternal high-fat diet
Emerging evidence suggests that the in utero environment is not sterile as once presumed. Work in the mouse demonstrated transmission of commensal bacteria from mother to fetus during gestation, though it is uncl...
Citation: Genome Medicine 2016 8:77 -
Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials
The effects of probiotic supplementation on fecal microbiota composition in healthy adults have not been well established. We aimed to provide a systematic review of the potential evidence for an effect of pro...
Citation: Genome Medicine 2016 8:52 -
NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets
Binding of peptides to MHC class I molecules (MHC-I) is essential for antigen presentation to cytotoxic T-cells.
Citation: Genome Medicine 2016 8:33 -
pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens
Cancer immunotherapy has gained significant momentum from recent clinical successes of checkpoint blockade inhibition. Massively parallel sequence analysis suggests a connection between mutational load and res...
Citation: Genome Medicine 2016 8:11 -
A 26-hour system of highly sensitive whole genome sequencing for emergency management of genetic diseases
While the cost of whole genome sequencing (WGS) is approaching the realm of routine medical tests, it remains too tardy to help guide the management of many acute medical conditions. Rapid WGS is imperative in...
Citation: Genome Medicine 2015 7:100 -
Rapid metagenomic identification of viral pathogens in clinical samples by real-time nanopore sequencing analysis
We report unbiased metagenomic detection of chikungunya virus (CHIKV), Ebola virus (EBOV), and hepatitis C virus (HCV) from four human blood samples by MinION nanopore sequencing coupled to a newly developed, ...
Citation: Genome Medicine 2015 7:99 -
Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences
Mycobacterium tuberculosis drug resistance (DR) challenges effective tuberculosis disease control. Current molecular tests examine limited numbers of mutations, and although whole genome ...
Citation: Genome Medicine 2015 7:51 -
Complex host genetics influence the microbiome in inflammatory bowel disease
Human genetics and host-associated microbial communities have been associated independently with a wide range of chronic diseases. One of the strongest associations in each case is inflammatory bowel disease (...
Citation: Genome Medicine 2014 6:107 -
Exome sequencing resolves apparent incidental findings and reveals further complexity of SH3TC2 variant alleles causing Charcot-Marie-Tooth neuropathy
The debate regarding the relative merits of whole genome sequencing (WGS) versus exome sequencing (ES) centers around comparative cost, average depth of coverage for each interrogated base, and their relative ...
Citation: Genome Medicine 2013 5:57 -
Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing
Patients with prostate cancer may present with metastatic or recurrent disease despite initial curative treatment. The propensity of metastatic prostate cancer to spread to the bone has limited repeated sampli...
Citation: Genome Medicine 2013 5:30 -
FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States
Population screening for FMR1 mutations has been a topic of considerable discussion since the FMR1 gene was identified in 1991. Advances in understanding the molecular basis of fragile X syndrome (FXS) and in gen...
Citation: Genome Medicine 2012 4:100 -
Future medical applications of single-cell sequencing in cancer
Advances in whole genome amplification and next-generation sequencing methods have enabled genomic analyses of single cells, and these techniques are now beginning to be used to detect genomic lesions in indiv...
Citation: Genome Medicine 2011 3:31 -
Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes
Skeletal muscle insulin resistance (IR) is considered a critical component of type II diabetes, yet to date IR has evaded characterization at the global gene expression level in humans. MicroRNAs (miRNAs) are ...
Citation: Genome Medicine 2010 2:9 -
The Human Gene Mutation Database: 2008 update
The Human Gene Mutation Database (HGMD®) is a comprehensive core collection of germline mutations in nuclear genes that underlie or are associated with human inherited disease. Here, we summarize the history of t...
Citation: Genome Medicine 2009 1:13